Also, 3D spheroids (containing a cell population enriched in cancer stem cells) from ER-positive breast cancer cell lines are sensitive to therapeutic targeting of MCT1/2, via inhibiting the uptake of mitochondrial fuels (ketone bodies and lactate) (57). The gene discussed is SLC16A1; the disease is cancer.